Identification of a variant estrogen receptor lacking exon 4 and its coexpression with wild-type estrogen receptor in ovarian carcinomas

Clinical Cancer Research

Volumn 2, Issue 12, 1996, Pages 2029-2035

  Park, Weonmee ^a   Choi, Jung Joo ^a   Hwang, Eun Seong ^a   Lee, Je Ho ^a  

^a Samsung Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; OVARY CARCINOMA; PRIORITY JOURNAL;

ALTERNATIVE SPLICING; CLONING, MOLECULAR; DNA, COMPLEMENTARY; EXONS; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OVARIAN NEOPLASMS; RECEPTORS, ESTROGEN; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0030472694     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Kumar, V., Green, S., Stack, G., Berry, M., Jin, J-R., and Chambon, P. Functional analysis of the human estrogen receptor. Cell, 51: 941-951, 1987.
2. Kumar, V., Green, S., Staub, A., and Chambon, P. Localization of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J., 5: 2231-2236, 1986.
3. Fawell, SE., Lees, JA., White, R., and Parker, M. Characterization and colocalization of steroid binding and dimenzation activities in the mouse estrogen receptor. Cell, 60: 953-962, 1990.
4. Tora, L., White, J., Brou, C., Tasset, D , Webster, N., Scheer, E., and Chambon, P. The human estrogen receptor has two independent non-acidic transcriptional activation function. Cell, 59: 477-487, 1989.
5. Graham, M. L., II, Krett, N. L., Miller, L. A., Leslie, K. K., Gordon, D. F., Wood, W. M., Wei, L. L., and Horwitz, K. B. T47Dco cells, genetically unstable and containing estrogen receptor mutations, are a model for the progression of breast cancers to hormone resistance. Cancer Res , 50: 6208-6217, 1990.
6. Fuqua, S. A., Fitzgerald, S. D , Chamness, G. C., Tandon, A. K., McDonnell, D. P., Nawaz, Z., O'Malley, B. W., and McGuire, W. L. Variant human breast tumor estrogen receptor with constitutive transcriptional activity Cancer Res., 51: 105-109, 1991.
7. Ince, B. A., Zhuang, Y., Wrenn, C. K., Shapiro, D. J., and Katzenellenbogen, B. S Powerful dominant negative mutants of the human estrogen receptor J. Biol. Chem., 268: 14026-14032, 1993.
8. Castles, C G., Fuqua, S. A W , Klotz, D. M., and Hill, S. M. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line. Cancer Res., 53: 5934-5939, 1993
9. Zhang, Q-X., Borg, A., and Fuqua, S. A. An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer. Cancer Res., 53: 5882-5884, 1993.
10. Fuqua, S. A. W., Fitzgerald, S. D., Allred, D. C., Elledge, R. M., Nawaz, Z., McDonnell, D. P., O'Malley, B. W., Greene, G. L., and McGuire, W. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res., 52: 483-486, 1992.
11. Skipper, S. K., Young, L. J., Bergeron, J. M., Tetzlaff, M. T., Osborn, C. T., and Crews, D. Identification of an isoform of the estrogen receptor messenger RNA lacking exon four and present in brain. Proc. Natl. Acad. Sci. USA, 90: 7172-7175, 1993.
12. Pfeffer, U., Fecarotta, E., Castagnetta, L., and Vidali, G. Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines. Cancer Res., 53: 741-743, 1993.
13. Pfeffer, U., Fecarotta, E., and Vidali, G. Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and in MCF-7 cells. Cancer Res., 55: 2158-2165, 1995.
14. Wang, Y., and Miksicek, R. J. Identification of a dominant negative form of the human estrogen receptor. Mol. Endocrinol., 5: 1707-1715, 1991.
15. McGuire, W. L., Chamness, G. C., and Fuqua, S. A. W. Estrogen receptor variants in clinical breast cancer Mol. Endocrinol., 5: 1571-1577, 1991.
16. Koehorst, S. G. A , Cox, J. J., Donker, G. H., Lopes da Silva, S., Burbach, J. P. H., Thijssen, J. H. H., and Blankenstein, M. A. Functional analysis of an alternatively spliced estrogen receptor lacking exon 4 isolated from MCF-7 breast cancer cells and meningioma tissue. Mol. Cell. Endocrinol., 101: 237-245, 1994.
17. Iglehart, J. D. The breast. In: D. C. Sabiston (ed.), Textbook of Surgery, pp. 510-550. Philadelphia: W. B. Saunders Co, 1991.
18. Ricketts, D. L., Turnbull, L., Ryall, G., Bakhshi, R., Rawson, N. S. B., Gazet, J-C., Nolan, C., and Coombes, R. C. Estrogen and progesterone receptors in the normal female breast. Cancer Res., 51: 1817-1822, 1991.
19. Langdon, S. P., Hawkes, N. M., Lawrie, S. S., Hawkins, R. A., Tesdale, A. L., and Crew, A. J. Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines. Br. J. Cancer, 62: 213-216, 1990.
20. Langdon, S. P., Hirst, G. L., Miller, E. P., Hawkins, R. A., Tesdale, A. L., Smyth, J. F., and Miller, W. R The regulation of growth and protein expression by estrogen in vitro. J. Steroid Biochem. Mol. Biol. 50: 131-135, 1994.
21. Rowlands, C., Krishnan, V., Wang, X., Santostefano, M., Safe, S., Miller, W. R., and Langdon, S. Characterization of the aryl hydrocarbon receptor and aryl hydrocarbon responsiveness in human ovarian carcinoma cell lines. Cancer Res., 53: 1802-1807, 1993.
22. Langdon, S. P., Ritchie, A., Young, K., Crew, A. J , Sweeting, V., Bramley, T., Hiller, S., Hawkins, R. A., Tesdale, A. L., and Smyth, J. F. Contrasting effects of 17 β-estradiol on the growth of human ovarian carcinoma cells in vitro and in vivo. Int. J. Cancer. 55: 459-464, 1993.
23. Harding, M., Cowan, S., Hole, D., Cassidy, L., Kitchener, H., Davis, J., and Leake, R. Estrogen and progesterone receptors in ovarian cancer. Cancer (Phila.), 65: 486-491, 1990.
24. Nash, J. D., Ozols, R F., Smyth, J. F., and Hamilton, T. C. Estrogen and anti-estrogen effects on the growth of human epithelial ovarian cancer in vitro. Obstet. Gynecol., 73: 1009-1016, 1989.
25. Sawada, M., Terada, N., Wada, A., Mori, Y., Yamasaki, M., and Saga, T. Estrogen- and androgen-responsive growth of human ovarian adenocarcinoma heterotransplanted into nude mice. Int. J. Cancer, 45: 359-363, 1990
26. Kieback, D. G., Press, M. F., Atkinsono, E. N., Edwards, G. L., Mobus, V. J., Runnebaum, I. B., Kreienberg, R., and Jones, L. A. Prognostic significance of estrogen receptor expression in ovarian cancer. Anticancer Res., 13: 2489-2496, 1993.
27. Kaufman, R J , Davis, M. V. Pathak, V. K., and Hershey, J. W. The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs. Mol. Cell. Biol., 9: 946-958, 1989.
28. Gorman, C. M., Moffat, L. F., and Howard, B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol., 2: 1044-1051, 1982.
29. Quilliam, A. L., Huff, S. Y., Rabun, K. M., Wei, W., Park, W., Broek, D., and Der, C. J. Membrane-targeting potentiates guanine nucleotide exchange factor CDC25 and SOS1 activation of Ras transforming activity. Proc. Natl. Acad. Sci. USA, 91: 8512-8516, 1994.
30. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, Ed. 2. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1987.
31. Green S., Walter, P., Kumar, V., Krust, A., Bornert, J-M., Argos, P., and Chambon, P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature (Lond.), 320: 134-139, 1986.
32. Ponglikitmongkol, M., Green, S., and Chambon, P. Genomic organization of the human oestrogen receptor gene. EMBO J., 7: 3385-3388, 1988.
33. Ylikomi, T., Bocquel, M. T., Berry, M., Gronemeyer, H., and Chambon, P. Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors. EMBO J., 11: 3681-3694, 1992.
34. Kumar, V. J., Green, S., Stack, G., Berry, M., Jin, J-R., and Chambon, P. Functional domains of the human estrogen receptor. Cell, 55: 145-156, 1988.
35. Lang, I., Scholz, M., and Peters, R. Molecular mobility and nucleocytoplasmic flux in hepatoma. J. Cell Biol., 102: 1183-1190, 1986.
36. Peters, R. Nucleo-cytoplasmic flux and intracellular mobility in single hepatocytes measured by fluorescence microphotolysis. EMBO J., 3: 1831-1836, 1984.
37. Paine, P. L., Moore, L. C., and Horowitz, S. B. Nuclear envelope permeability. Nature (Lond.), 254: 109-114, 1975.
38. Arnold, S. F., Obourn, J. D., Jaffe, H , and Notides, A. C. Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by src family tyrosine kinases in vitro. Mol. Endocrinol., 9: 24-33, 1995.
39. Arnold, S. F., Obourn, J. D., Yudt, M. R., Carter, J. H., and Notides, A, C. In vivo and in vitro phosphorylation of the human estrogen receptor. J. Steroid Biochem. Mol. Biol., 52: 159-171, 1995.
40. Arnold, S. F., Obourn, J. D., Jaffe, H., and Notides, A. C Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor. Mol. Endocrinol., 8: 1208-1214, 1994.